UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
(Address of principal executive offices, zip code)
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered |
The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ◻ | Accelerated filer ◻ | |
Smaller reporting company | ||
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of shares of the registrant’s common stock outstanding as of October 31, 2023:
GSI TECHNOLOGY, INC.
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023
Page | ||
2 | ||
2 | ||
3 | ||
4 | ||
5 | ||
6 | ||
7 | ||
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 19 | |
26 | ||
27 | ||
PART II — OTHER INFORMATION | ||
28 | ||
46 | ||
46 | ||
47 |
1
PART I — FINANCIAL INFORMATION
Item 1.Financial Statements (unaudited)
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
September 30, | March 31, | ||||||
2023 |
| 2023 |
| ||||
(In thousands, except share | |||||||
ASSETS | |||||||
Cash and cash equivalents |
| $ | |
| $ | | |
Short-term investments |
| |
| | |||
Accounts receivable, net |
| |
| | |||
Inventories |
| |
| | |||
Prepaid expenses and other current assets |
| |
| | |||
Total current assets |
| |
| | |||
Property and equipment, net |
| |
| | |||
Operating lease right-of-use assets | | | |||||
Goodwill | | | |||||
Intangible assets, net | | | |||||
Deposits |
| |
| | |||
Total assets |
| $ | |
| $ | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Accounts payable ($ |
| $ | |
| $ | | |
Lease liabilities, current | | | |||||
Accrued expenses and other liabilities |
| |
| | |||
Total current liabilities |
| |
| | |||
Deferred tax liability |
| |
| | |||
Lease liabilities, non-current | | | |||||
Contingent consideration, non-current | | | |||||
Total liabilities |
| |
| | |||
Commitments and contingencies (Note 9) | |||||||
Stockholders’ equity: | |||||||
Preferred stock: $ |
|
| |||||
Common Stock: $ |
| |
| | |||
Additional paid-in capital |
| |
| | |||
Accumulated other comprehensive loss |
| ( |
| ( | |||
Retained deficit |
| ( |
| ( | |||
Total stockholders’ equity |
| |
| | |||
Total liabilities and stockholders’ equity |
| $ | |
| $ | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||
2023 | 2022 | 2023 | 2022 |
| |||||||||
(In thousands, except per share amounts) | (In thousands, except per share amounts) | ||||||||||||
Net revenues |
| $ | |
| $ | |
| $ | |
| $ | | |
Cost of revenues ($ |
| |
| |
| |
| | |||||
Gross profit |
| |
| |
| |
| | |||||
Operating expenses: | |||||||||||||
Research and development |
| | | | | ||||||||
Selling, general and administrative |
| | | | | ||||||||
Total operating expenses |
| |
| |
| |
| | |||||
Loss from operations |
| ( |
| ( |
| ( |
| ( | |||||
Interest income, net |
| | | | | ||||||||
Other expense, net |
| ( | ( | ( | ( | ||||||||
Loss before income taxes |
| ( |
| ( |
| ( |
| ( | |||||
Provision for income taxes |
| | | | | ||||||||
Net loss |
| $ | ( |
| $ | ( |
| $ | ( |
| $ | ( | |
Net loss per share: | |||||||||||||
Basic |
| $ | ( |
| $ | ( |
| $ | ( |
| $ | ( | |
Diluted |
| $ | ( |
| $ | ( |
| $ | ( |
| $ | ( | |
Weighted average shares used in per share calculations: | |||||||||||||
Basic |
| |
| | | | |||||||
Diluted |
| |
| | | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited)
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||
2023 | 2022 | 2023 | 2022 |
| |||||||||
(In thousands) | (In thousands) | ||||||||||||
Net loss |
| $ | ( |
| $ | ( |
| $ | ( |
| $ | ( | |
Net unrealized gain (loss) on available-for-sale investments |
| |
| |
| |
| ( | |||||
Total comprehensive loss |
| $ | ( |
| $ | ( |
| $ | ( |
| $ | ( |
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
Accumulated | |||||||||||||||||
Additional | Other | Total | |||||||||||||||
Common Stock | Paid-in | Comprehensive | Retained | Stockholders' | |||||||||||||
| Shares |
| Amount |
| Capital |
| Loss |
| Deficit |
| Equity | ||||||
Three months ended September 30, 2023 | (In thousands, except share amounts) | ||||||||||||||||
Balance, June 30, 2023 | | $ | | $ | | $ | ( | $ | ( | $ | | ||||||
Issuance of common stock pursuant to an At-the-Market offering, net of offering costs of $ | | — | | — | — | | |||||||||||
Stock-based compensation expense | — | — | | — | — | | |||||||||||
Net loss | — | — | — | — | ( | ( | |||||||||||
Net unrealized gain on available-for-sale investments | — | — | — | | — | | |||||||||||
Balance, September 30, 2023 | | $ | | $ | | $ | ( | $ | ( | $ | | ||||||
Accumulated | |||||||||||||||||
Additional | Other | Total | |||||||||||||||
Common Stock | Paid-in | Comprehensive | Retained | Stockholders' | |||||||||||||
Shares |
| Amount |
| Capital |
| Loss |
| Earnings |
| Equity | |||||||
Three months ended September 30, 2022 | (In thousands, except share amounts) | ||||||||||||||||
Balance, June 30, 2022 | | $ | | $ | | $ | ( | $ | | $ | | ||||||
Stock-based compensation expense | — | — | | — | — | | |||||||||||
Net loss | — | — | — | — | ( | ( | |||||||||||
Net unrealized gain on available-for-sale investments | — | — | — | | — | | |||||||||||
Balance, September 30, 2022 | | $ | | $ | | $ | ( | $ | | $ | |
Accumulated | |||||||||||||||||
Additional | Other | Total | |||||||||||||||
Common Stock | Paid-in | Comprehensive | Retained | Stockholders' | |||||||||||||
| Shares |
| Amount |
| Capital |
| Loss |
| Deficit |
| Equity | ||||||
Six months ended September 30, 2023 | (In thousands, except share amounts) | ||||||||||||||||
Balance, March 31, 2023 | | $ | | $ | | $ | ( | $ | ( | $ | | ||||||
Issuance of common stock under employee stock option plans | | — | | — | — | | |||||||||||
Issuance of common stock pursuant to an At-the-Market offering, net of offering costs of $ | | — | | — | — | | |||||||||||
Stock-based compensation expense | — | — | | — | — | | |||||||||||
Net loss | — | — | — | — | ( | ( | |||||||||||
Net unrealized gain on available-for-sale investments | — | — | — | | — | | |||||||||||
Balance, September 30, 2023 | | $ | | $ | | $ | ( | $ | ( | $ | | ||||||
Accumulated | |||||||||||||||||
Additional | Other | Total | |||||||||||||||
Common Stock | Paid-in | Comprehensive | Retained | Stockholders' | |||||||||||||
Shares |
| Amount |
| Capital |
| Loss |
| Earnings |
| Equity | |||||||
Six months ended September 30, 2022 | (In thousands, except share amounts) | ||||||||||||||||
Balance, March 31, 2022 | | $ | | $ | | $ | ( | $ | | $ | | ||||||
Issuance of common stock under employee stock option plans | | | | — | — | | |||||||||||
Stock-based compensation expense | — | — | | — | — | | |||||||||||
Net loss | — | — | — | — | ( | ( | |||||||||||
Net unrealized loss on available-for-sale investments | — | — | — | ( | — | ( | |||||||||||
Balance, September 30, 2022 | | $ | | $ | | $ | ( | $ | | $ | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six Months Ended September 30, | |||||||
2023 | 2022 |
| |||||
(In thousands) | |||||||
Cash flows from operating activities: | |||||||
Net loss |
| $ | ( |
| $ | ( | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Allowance for credit losses |
| ( |
| ( | |||
Provision for excess and obsolete inventories |
| |
| | |||
Non-cash lease expense | | | |||||
Change in fair value of contingent consideration | ( | ( | |||||
Depreciation and amortization |
| |
| | |||
Stock-based compensation |
| |
| | |||
Amortization of premium on investments |
| ( |
| | |||
Changes in assets and liabilities: | |||||||
Accounts receivable |
| |
| ( | |||
Inventories |
| |
| ( | |||
Prepaid expenses and other assets |
| |
| ( | |||
Accounts payable |
| ( |
| | |||
Accrued expenses and other liabilities |
| ( |
| ( | |||
Net cash used in operating activities |
| ( |
| ( | |||
Cash flows from investing activities: | |||||||
Maturities of short-term investments |
| | | ||||
Purchases of property and equipment |
| ( | ( | ||||
Net cash provided by investing activities |
| |
| | |||
Cash flows from financing activities: | |||||||
Proceeds from issuance of common stock under At-the-Market offering, net of offering costs of $ | | — | |||||
Proceeds from issuance of common stock under employee stock plans |
| | | ||||
Net cash provided by financing activities |
| |
| | |||
Net decrease in cash and cash equivalents |
| ( |
| ( | |||
Cash and cash equivalents at beginning of the period |
| | | ||||
Cash and cash equivalents at end of the period |
| $ | |
| $ | | |
Non-cash investing and financing activities: | |||||||
Operating lease right-of-use assets exchanged for lease obligations | $ | | $ | | |||
Supplemental cash flow information: | |||||||
Net cash paid for income taxes |
| $ | |
| $ | | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
GSI TECHNOLOGY, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1—THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the interim financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein. The Company believes that the disclosures are adequate to make the information not misleading. However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023.
The consolidated results of operations for the six months ended September 30, 2023 are not necessarily indicative of the results to be expected for the entire fiscal year.
Reclassifications
Certain amounts in the fiscal 2022 condensed consolidated financial statements have been reclassified to conform to the fiscal 2023 presentation.
Significant accounting policies
There have been no material changes to our significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023.
Government Agreements
From time to time, the Company may enter into agreements with federal government agencies. GAAP does not have specific accounting standards covering agreements between the government and business entities. The Company applies International Accounting Standards 20 (“IAS 20”), Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for agreements entered into with the government. Under IAS 20, government grants or awards are initially recognized when there is reasonable assurance the conditions of the grant or award will be met and the grant or award will be received. After initial recognition, government grants or awards are recognized on a systematic basis in a manner consistent with the manner in which the Company recognizes the underlying costs for which the grant or award is intended to compensate. The Company follows ASC 832, Disclosures by Business Entities about Government Assistance, with respect to the disclosures of government grants or awards.
.
Credit Losses—Marketable Securities
For marketable securities in an unrealized loss position, the Company periodically assesses its portfolio for impairment. The assessment first considers the intent or requirement to sell the marketable security. If either of these criteria are met, the amortized cost basis is written down to fair value through earnings.
7
Beginning April 1, 2023, if the criteria above are not met, the Company evaluates whether the decline resulted from credit losses or other factors by considering the extent to which fair value is less than amortized cost, any changes to the rating of the marketable security by a rating agency, and any adverse conditions specifically related to the marketable security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the marketable security is compared to the amortized cost basis of the marketable security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any other impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive loss.
Credit Losses—Accounts Receivable
Accounts receivable are recorded at the amounts billed less estimated allowances for credit losses for any potential uncollectible amounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from a customer’s inability to make required payments. The Company considers factors such as historical experience, credit quality, age of the accounts receivable balances, and economic conditions that may affect a customer’s ability to pay. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success.
Risk and uncertainties
The decline in the global economic environment due to, among other things, rising interest rates, worldwide inflationary pressures and significant fluctuations in energy prices has affected the business activities of the Company, its customers, suppliers, and other business partners in the fiscal year ended March 31, 2023 and into the six months ended September 30, 2023.
Our software development and certain regional sales activities for our APU product offerings occur in Israel. Our Vice President, Associative Computing, along with a team of software development experts are based in our Israel facility. This team is needed for the development of the various levels of software required in the use of our APU product offering. Proof of concept customers for our SAR imagine processing acceleration system are also based in Israel. We are closely monitoring developments in the evolving military conflict with Hamas that began on October 7, 2023 including potential impacts to our business, customers, employees and operations in Israel. At this time, the impact on GSI Technology are uncertain and subject to change given the volatile nature of the situation, but adverse changes in the military conditions in Israel could harm our business and our stock price could decline.
The Company believes that during the next 12 months disruptions in the capital markets as a result of rising interest rates, worldwide inflationary pressures, significant fluctuations in energy prices and the decline in the global economic environment could impact general economic activity and demand in the Company’s end markets. Additionally, fluctuations in customer demand due to previous buffer stock purchases during the semiconductor supply shortage may negatively impact near-term revenues.
Accounting pronouncements effective for fiscal 2024
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Application of the amendments is through a cumulative-effect adjustment to retained earnings as of the effective date. Adoption of this standard on April 1, 2023 did not have a material impact on the Company’s consolidated financial statements and related disclosures.
8
NOTE 2—REVENUE RECOGNITION
The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.
The Company’s customer contracts, which may be in the form of purchase orders, contracts or purchase agreements, contain performance obligations for delivery of agreed upon products. Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the same accounting period). Transfer of control occurs at the point at which delivery has occurred, title and the risks and rewards of ownership have passed to the customer, and the Company has a right to payment. The Company recognizes revenue upon shipment of the product.
Because all of the Company’s performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption practical expedient and, therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.
The Company adjusts the transaction price for variable consideration. Variable consideration is not typically significant and primarily results from stock rotation rights and quick pay discounts provided to certain distributors. As a practical expedient, the Company is recognizing the of obtaining a contract, specifically commission expenses that have a period of benefit of less than twelve months, as an expense when incurred. Additionally, the Company has adopted an accounting policy to recognize shipping costs that occur after control transfers to the customer as a fulfillment activity.
The Company’s contracts with customers do not typically include extended payment terms. Payment terms vary by contract type and type of customer and generally range from
The Company records revenue net of sales tax, value added tax, excise tax and other taxes collected concurrent with product sales. The impact of such taxes on products sales is immaterial.
The Company warrants its products to be free of defects generally for a period of
Substantially all of the Company’s revenue is derived from sales of SRAM products, which represent approximately
Nokia, the Company’s largest customer, purchases products directly from the Company and through contract manufacturers and distributors. Based on information provided to the Company by its contract manufacturers and distributors, purchases by Nokia represented approximately
See “Note 12 — Segment and Geographic Information” for revenue by shipment destination.
9
The following table presents the Company’s revenue disaggregated by customer type.
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||
2023 | 2022 | 2023 | 2022 |
| |||||||||
(In thousands) | (In thousands) | ||||||||||||
Contract manufacturers |
| $ | |
| $ | |
| $ | |
| $ | | |
Distribution | | | | | |||||||||
OEMs | | | | | |||||||||
$ | | $ | | $ | | $ | | ||||||
NOTE 3—NET LOSS PER COMMON SHARE
The Company uses the treasury stock method to calculate the weighted average shares used in computing diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||
(In thousands, except per share amounts) | (In thousands, except per share amounts) | ||||||||||||
Net loss |
| $ | ( |
| $ | ( |
| $ | ( |
| $ | ( | |
Denominators: | |||||||||||||
Weighted average shares—Basic |
| | | | | ||||||||
Dilutive effect of employee stock options | — | — | — | — | |||||||||
Dilutive effect of employee stock purchase plan options |
| — | — | — | — | ||||||||
Weighted average shares—Dilutive |
| |
| |
| |
| | |||||
Net loss per common share—Basic |
| $ | ( |
| $ | ( |
| $ | ( | $ | ( | ||
Net loss per common share—Diluted |
| $ | ( |
| $ | ( |
| $ | ( | $ | ( |
The following shares of common stock underlying outstanding stock options and unissued ESPP shares, determined on a weighted average basis, were excluded from the computation of diluted net loss per share as they had an anti-dilutive effect:
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||
2023 | 2022 | 2023 | 2022 |
| |||||
(In thousands) | (In thousands) | ||||||||
Shares underlying options and ESPP shares |
| | | | |
NOTE 4—BALANCE SHEET DETAIL
September 30, 2023 | March 31, 2023 |
| |||||
(In thousands) | |||||||
Inventories: | |||||||
Work-in-progress |
| $ | |
| $ | | |
Finished goods |
| |
| | |||
Inventory at distributors |
| |
| | |||
| $ | |
| $ | |
10
September 30, 2023 | March 31, 2023 |
| |||||
(In thousands) | |||||||
Accounts receivable, net: | |||||||
Accounts receivable |
| $ | |
| $ | | |
Less: Allowances for credit losses |
| ( |
| ( | |||
| $ | |
| $ | |
September 30, 2023 | March 31, 2023 |
| |||||
(In thousands) | |||||||
Prepaid expenses and other current assets: | |||||||
Prepaid tooling and masks | $ | | $ | | |||
Other receivables | | | |||||
Other prepaid expenses and other current assets | | | |||||
$ | | $ | |
September 30, 2023 | March 31, 2023 |
| |||||
(In thousands) | |||||||
Property and equipment, net: | |||||||
Computer and other equipment | $ | | $ | | |||
Software | | | |||||
Land | | | |||||
Building and building improvements | | | |||||
Furniture and fixtures | | | |||||
Leasehold improvements | | | |||||
| | ||||||
Less: Accumulated depreciation | ( | ( | |||||
$ | | $ | |
Depreciation expense was $
The following tables summarize the components of intangible assets and related accumulated amortization balances at September 30, 2023 and March 31, 2023 (in thousands):
As of September 30, 2023 | ||||||||||
| Gross |
| Accumulated |
| Net Carrying |
| ||||
Intangible assets: |
|
|
| |||||||
Product designs | $ | | $ | ( | $ | — | ||||
Patents | | ( | | |||||||
Software | | ( | — | |||||||
Total | $ | | $ | ( | $ | |
As of March 31, 2023 | ||||||||||
| Gross |
| Accumulated |
| Net Carrying |
| ||||
Intangible assets: | ||||||||||
Product designs | $ | | $ | ( | $ | — | ||||
Patents | | ( | | |||||||
Software | | ( | — | |||||||
Total | $ | | $ | ( | $ | |
11
Amortization of intangible assets included in cost of revenues was $
The Company reviews identifiable amortizable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset over its fair value. The Company identified a potential impairment indicator for the finite lived intangible assets and performed a recoverability test by comparing the sum of the estimated undiscounted future cash flows of the asset group to the carrying amount as of March 31, 2023. The result of the recoverability test indicated that the sum of the expected future cash flows was greater than the carrying amount of the finite lived intangible assets. Based on the uncertainty of forecasts inherent with a new product, events such as the failure to generate forecasted revenue from the APU product could result in a non-cash impairment charge in future periods.
As of September 30, 2023, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):
Fiscal year ending March 31, | ||||
2024 (remaining six months) | $ | | ||
2025 | | |||
2026 | | |||
2027 | | |||
2028 | | |||
Thereafter | | |||
Total | $ | |
September 30, 2023 | March 31, 2023 |
| |||||
(In thousands) | |||||||
Accrued expenses and other liabilities: | |||||||
Accrued compensation | $ | | $ | | |||
Accrued commissions | | | |||||
Income taxes payable | | | |||||
Outsourced design resources | | | |||||
Miscellaneous accrued expenses | | | |||||
$ | | $ | |
On November 30, 2022, the Company announced cost reduction initiatives which included an approximate
NOTE 5—GOODWILL
Goodwill represents the difference between the purchase price and the estimated fair value of the identifiable assets acquired and liabilities assumed in a business combination. The Company tests for goodwill impairment on an annual basis, or more frequently if events or changes in circumstances indicate that the asset is more likely than not impaired. The Company assesses goodwill for impairment on an annual basis on the last day of February in the fourth quarter of its fiscal year. The Company has
The Company had a goodwill balance of $
12
The Company completed its annual impairment test during the fourth quarter of fiscal 2023 and concluded that there was
NOTE 6—INCOME TAXES
The current portion and long-term portion of the Company’s income tax liability related to unrecognized tax benefits was $
Management believes that within the next twelve months the Company will not have a significant reduction in uncertain tax benefits, including interest and penalties, related to positions taken with respect to credits and loss carryforwards on previously filed tax returns.
The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes in the Condensed Consolidated Statements of Operations.
The Company is subject to taxation in the United States and various state and foreign jurisdictions. Fiscal years 2013 through 2022 remain open to examination by federal tax authorities, and fiscal years 2012 through 2022 remain open to examination by California tax authorities. Fiscal years 2020, 2021, 2022 and 2023 are subject to audit by the Israeli tax authorities.
For the six months ended September 30, 2023 and September 30, 2022, the Company incurred income tax expense of $
NOTE 7—FINANCIAL INSTRUMENTS
Fair value measurements
Authoritative accounting guidance for fair value measurements provides a framework for measuring fair value and related disclosures. The guidance applies to all financial assets and financial liabilities that are measured on a recurring basis. The guidance requires fair value measurement to be classified and disclosed in one of the following three categories:
Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities. The fair value of available-for-sale securities included in the Level 1 category is based on quoted prices that are readily and regularly available in an active market. As of September 30, 2023, the Level 1 category included money market funds of $
Level 2: Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets at the measurement date; quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly. The fair value of available-for-sale securities included in the Level 2 category is based on the market values obtained from an independent pricing service that were evaluated using pricing models that vary by asset class and may incorporate available trade, bid and other market information and price quotes from well-established independent pricing vendors and broker-dealers. As of September 30, 2023, the Level 2 category included short-term investments of $
Level 3: Valuations based on inputs that are unobservable and involve management judgment and the reporting entity’s own assumptions about market participants and pricing. As of September 30, 2023, the
13
Company’s Level 3 financial instruments measured at fair value on the Condensed Consolidated Balance Sheets consisted of the contingent consideration liability related to the acquisition of MikaMonu. The fair value of the contingent consideration liability was initially determined as of the acquisition date using unobservable inputs. These inputs included the estimated amount and timing of future cash flows, the probability achievement of the forecast and a risk-adjusted discount rate of approximately
The fair value of financial assets measured on a recurring basis is as follows (in thousands):
Fair Value Measurements at Reporting Date Using | |||||||||||||
Quoted Prices | |||||||||||||
in Active | Significant | ||||||||||||
Markets for | Other | Significant | |||||||||||
Identical Assets | Observable | Unobservable | |||||||||||
and Liabilities | Inputs | Inputs | |||||||||||
| September 30, 2023 |
| (Level 1) |
| (Level 2) |
|